Related Experiment Video
Updated: Jul 13, 2026
04:50
Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
[Current therapeutic strategy for rheumatoid arthritis]
J Wollenhaupt1, R Alten, H Burkhardt
1Klinikum Eilbek, Hamburg. wollenhaupt@rheumatologikum.de
MMW Fortschritte Der Medizin
|July 12, 2007
Summary
Early diagnosis is key for successful rheumatoid arthritis treatment. Therapy often starts with methotrexate, potentially combined with other drugs like cytokine antagonists or DMARD monotherapies, aiming for remission.
Area of Science:
- Rheumatology
- Immunology
- Pharmacology
Context:
- Rheumatoid arthritis (RA) treatment success hinges on early detection.
- Methotrexate is a common first-line therapy for RA.
- Disease progression, including radiographic erosion, influences treatment decisions.
Purpose:
- To outline current therapeutic strategies for rheumatoid arthritis.
- To describe the role of methotrexate and other disease-modifying antirheumatic drugs (DMARDs) in RA management.
- To highlight the objective of achieving remission in RA patients.
Summary:
- Successful rheumatoid arthritis management relies on prompt diagnosis and tailored therapy.
- Initial treatment typically involves methotrexate, with options for combination or alternative therapies like cytokine antagonists and DMARD monotherapies based on disease severity.
- The ultimate goal of contemporary RA treatment is to induce and maintain remission.
Impact:
- Provides a concise overview of RA treatment paradigms for clinicians and researchers.
- Emphasizes the importance of early intervention and personalized treatment approaches in managing rheumatoid arthritis.
- Informs understanding of therapeutic options and goals for improving patient outcomes in RA.
Related Concept Videos
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...